Crossmark

An integrated microbiome-drug interaction and bioinformatics approach identifies active deglycosylated and glycosidic chain metabolites of Platycodin D targeting PTPN2/HIF1A in acute lung injury

Crossref DOI link: https://doi.org/10.1186/s13062-026-00779-3

Published Online: 2026-04-15

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhong, Yuanhan

Peng, Yu

Zhang, Shouwen

Wen, Liyun

Liu, Guangpeng

Xu, Bingbing

Liang, Yonghong

Huang, Huiliang

He, Junwei

Feng, Yong

Zeng, Jinxiang

Liang, Jian
License Information

Text and Data Mining valid from 2026-04-15

Version of Record valid from 2026-05-25
More Information

Article History

Received: 25 January 2026

Accepted: 7 April 2026

First Online: 15 April 2026

Declarations

:

: All procedures complied with institutional and national guidelines for the care and use of laboratory animals and were approved by the Animal Care and Use Committee of Jiangxi University of Chinese Medicine (approval No. JZLLSC20250550).

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below